March 25, 2022
March 25, 2022
Categories

Enrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 17, 2022
March 17, 2022
Categories

NCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
March 15, 2022
March 15, 2022
Categories

The results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy

Do you like it?
Read more
March 10, 2022
March 10, 2022
Categories

Travel Funds Available for CRAs to Attend the Spring 2022 Group Meeting

Do you like it?
Read more
March 8, 2022
March 8, 2022
Categories

JAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer

Do you like it?
Read more
March 1, 2022
March 1, 2022
Categories

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group